Oral Bordetella

Verify with FDA CVM →

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Oral Bordetella

Administration Routes

OralUnknown

Species Affected

Dog 16

Most Affected Breeds

Retriever - Labrador 3
Setter - Irish Red 2
Crossbred Canine/dog 1
Pointing Dog - German Short-haired 1
Catahoula Leopard Dog 1
Terrier - Yorkshire 1
Maltese 1
Boxer (German Boxer) 1
Collie - Border 1
Rottweiler 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 6
Not eating 6
Diarrhoea 4
Decreased appetite 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Emesis 2
Vomiting 2
Hives (see also 'Skin') 2
Anorexia 2
Injection site bruising 2
Thrombocytopenia 2
Injection site swelling 2

Outcome Breakdown

Outcome Unknown
6 (37.5%)
Ongoing
5 (31.3%)
Recovered/Normal
5 (31.3%)

Data Summary

Metric Value
Total adverse event reports 16
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 1
Distinct breeds in reports 13
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Oral Bordetella Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 16 adverse event reports referencing Oral Bordetella, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Oral Bordetella. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Oral Bordetella reports are Dog (16 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Setter - Irish Red (2), Crossbred Canine/dog (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Oral Bordetella are Lethargy (see also Central nervous system depression in Neurological) (6), Not eating (6), Diarrhoea (4), Decreased appetite (3). Of the 16 reports with a coded outcome, Outcome Unknown is the leading category at 37.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Oral Bordetella.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial